1. Home
  2. COUR vs TVTX Comparison

COUR vs TVTX Comparison

Compare COUR & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COUR
  • TVTX
  • Stock Information
  • Founded
  • COUR 2012
  • TVTX 2008
  • Country
  • COUR United States
  • TVTX United States
  • Employees
  • COUR N/A
  • TVTX N/A
  • Industry
  • COUR Computer Software: Prepackaged Software
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • COUR Technology
  • TVTX Health Care
  • Exchange
  • COUR Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • COUR 1.3B
  • TVTX 1.5B
  • IPO Year
  • COUR 2021
  • TVTX N/A
  • Fundamental
  • Price
  • COUR $8.93
  • TVTX $15.50
  • Analyst Decision
  • COUR Hold
  • TVTX Strong Buy
  • Analyst Count
  • COUR 13
  • TVTX 16
  • Target Price
  • COUR $10.52
  • TVTX $33.33
  • AVG Volume (30 Days)
  • COUR 1.8M
  • TVTX 1.3M
  • Earning Date
  • COUR 07-24-2025
  • TVTX 07-31-2025
  • Dividend Yield
  • COUR N/A
  • TVTX N/A
  • EPS Growth
  • COUR N/A
  • TVTX N/A
  • EPS
  • COUR N/A
  • TVTX N/A
  • Revenue
  • COUR $704,874,000.00
  • TVTX $273,533,000.00
  • Revenue This Year
  • COUR $6.70
  • TVTX $73.99
  • Revenue Next Year
  • COUR $4.88
  • TVTX $42.00
  • P/E Ratio
  • COUR N/A
  • TVTX N/A
  • Revenue Growth
  • COUR 7.25
  • TVTX 75.65
  • 52 Week Low
  • COUR $5.76
  • TVTX $7.93
  • 52 Week High
  • COUR $11.74
  • TVTX $25.29
  • Technical
  • Relative Strength Index (RSI)
  • COUR 58.87
  • TVTX 47.22
  • Support Level
  • COUR $8.47
  • TVTX $16.25
  • Resistance Level
  • COUR $8.77
  • TVTX $17.02
  • Average True Range (ATR)
  • COUR 0.28
  • TVTX 0.61
  • MACD
  • COUR 0.05
  • TVTX 0.05
  • Stochastic Oscillator
  • COUR 90.87
  • TVTX 38.10

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: